Study of Poziotinib in Japanese Patients With NSCLC
Clinical trial NCT04402008 · TERMINATED
Trial details
- NCT number
- NCT04402008
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-23
- Primary completion
- 2023-02-15
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.